Rating History for LB Pharmaceuticals Inc (LBRX) by Clear Street
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/26/2026 | Kaveri Pohlman | New Coverage | Buy (N/A) |
45.00 (N/A) |
28.12 (31.41) |
11.7% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/26/2026 | Kaveri Pohlman | New Coverage | Buy (N/A) |
45.00 (N/A) |
28.12 (31.41) |
11.7% | Details |